NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Proteomic Analysis of Formalin-fixed Prostate Cancer Tissue

Author(s): Hood BL, Darfler MM, Guiel TG, Furusato B, Lucas DA, Ringeisen BR, Sesterhenn IA, Conrads TP, Veenstra TD, Krizman DB

Publication: Mol Cell Proteomics, 2005, Vol. 4, Page 1741

PubMed ID: 16091476 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to assess the feasibility of conventional proteomic analysis in cells microdissected from formalin-fixed, paraffin-embedded (FFPE) prostate tissue specimens using a biochemical methodology for the recovery of soluble proteins and peptides.

Conclusion of Paper

Protein solubilization was achieved in microdissected FFPE cancerous prostate tissue. Subsequent proteomic analysis resulted in the identification of hundreds of unique proteins, including several prostate cancer markers such as prostate-specific antigen (PSA), prostatic acid phosphatase and macrophage inhibitory cytokine-1. Quantitative proteomic profiling of microdissected cells yielded region-specific protein expression as measured by 18O isotope labeling.

Studies

  1. Study Purpose

    To assess the applicability of microdissected cells from FFPE tissue sections for detection and quantitative analysis using microarray analysis following the biochemical recovery of soluble proteins and peptides.

    Summary of Findings:

    PSA was appropriately and dose-dependently detected in serially diluted protein extracts isolated from microdissected prostate regions, indicating successful application of FFPE microdissected cells and the protein microarray platform.

    Biospecimens
    Preservative Types
    • Formalin
    Diagnoses:
    • Neoplastic - Carcinoma
    • Neoplastic - Benign
    Platform:
    AnalyteTechnology Platform
    Protein Reverse phase protein microarray
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Aliquot size/volume 0.05 Dilution factor
    0.125 Dilution factor
    0.25 Dilution factor
    0.50 Dilution factor
  2. Study Purpose

    To determine the feasibility of peptide identification via conventional mass spectrometry in cells microdissected from FFPE tissue.

    Summary of Findings:

    Nano RPLC-mass spectrometry analysis of extracts from PSA-positive and -negative FFPE microdissected regions yielded thousands of unique tryptic peptides representing hundreds of unique proteins. Identified proteins encompassed a range of functions and included cytoskeletal, prostate-related, and signal transduction proteins. A portion of the identified peptides contained formylated lysl residues (6.5%), and oxidized methionine residues (53%). Although the number of peptides with arginyl and lysl termini were slightly elevated, they did not differ significantly from theorteical occurrence. The number of identified proteins containing an internal missed cleavage site was at the high end of the predicted spectrum (25%). Quantitative protein profiling yielded differential protein expression between the two microdissected regions (PCA-positive vs -negative).

    Biospecimens
    Preservative Types
    • Formalin
    Diagnoses:
    • Neoplastic - Benign
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Peptide GC-MS
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Analyte Extraction and Purification Analyte isolation method Tissue microdissection

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...